chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test normal, Brain neoplasm, Computerised tomogram abnormal, Diplopia, Facial pain
Clinical narrative: After receiving the vaccine I had a sore arm for about 3 days. About a week later I had facial numbness on the left side of my face. It became more gradual numbness and tingling. Going into the 2nd dose I started getting a sharp pain on the left side of my head above my ear. I went to my doctor's appointment, and they told me I had a tumor on the left side of my brain. I was self medicating with Tylenol 500mg and Ibuprofen 800mg. I was prescribed a 800mg ibuprofen that worked sometimes. They also put me on tramadol and it worked but I only took it for 3 weeks. When I went to see the neurosurgeon he did the gamma knife radiation treatment on me. I had a halo screwed to my head. 2 months later, I saw that neurosurgeon again and my tumor grew. He told me it was because of swelling. I had a hard time looking out of my left eye for a couple months after getting the gamma knife radiation treatment. When I used my eyes together I would see double. I cold only see clearly when looking out of one eye at a time. I occasionally still get pain on the side of my face. I still have the tumor, but I don't have numbness or tingling on my face anymore. I occasionally have sharp pains on the side of my head that comes and goes. After 9 months the tumor had went down.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Gamma radiation therapy to brain, Headache, Hypoaesthesia, Magnetic resonance imaging abnormal, Pain in extremity
Clinical narrative: After receiving the vaccine I had a sore arm for about 3 days. About a week later I had facial numbness on the left side of my face. It became more gradual numbness and tingling. Going into the 2nd dose I started getting a sharp pain on the left side of my head above my ear. I went to my doctor's appointment, and they told me I had a tumor on the left side of my brain. I was self medicating with Tylenol 500mg and Ibuprofen 800mg. I was prescribed a 800mg ibuprofen that worked sometimes. They also put me on tramadol and it worked but I only took it for 3 weeks. When I went to see the neurosurgeon he did the gamma knife radiation treatment on me. I had a halo screwed to my head. 2 months later, I saw that neurosurgeon again and my tumor grew. He told me it was because of swelling. I had a hard time looking out of my left eye for a couple months after getting the gamma knife radiation treatment. When I used my eyes together I would see double. I cold only see clearly when looking out of one eye at a time. I occasionally still get pain on the side of my face. I still have the tumor, but I don't have numbness or tingling on my face anymore. I occasionally have sharp pains on the side of my head that comes and goes. After 9 months the tumor had went down.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Spinal support, Swelling, Visual impairment
Clinical narrative: After receiving the vaccine I had a sore arm for about 3 days. About a week later I had facial numbness on the left side of my face. It became more gradual numbness and tingling. Going into the 2nd dose I started getting a sharp pain on the left side of my head above my ear. I went to my doctor's appointment, and they told me I had a tumor on the left side of my brain. I was self medicating with Tylenol 500mg and Ibuprofen 800mg. I was prescribed a 800mg ibuprofen that worked sometimes. They also put me on tramadol and it worked but I only took it for 3 weeks. When I went to see the neurosurgeon he did the gamma knife radiation treatment on me. I had a halo screwed to my head. 2 months later, I saw that neurosurgeon again and my tumor grew. He told me it was because of swelling. I had a hard time looking out of my left eye for a couple months after getting the gamma knife radiation treatment. When I used my eyes together I would see double. I cold only see clearly when looking out of one eye at a time. I occasionally still get pain on the side of my face. I still have the tumor, but I don't have numbness or tingling on my face anymore. I occasionally have sharp pains on the side of my head that comes and goes. After 9 months the tumor had went down.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Hyperhidrosis, Nausea, Vomiting
Clinical narrative: The client received her 1st dose Pfizer and approximately 20 mins. later the client stated she was nausea, dizzy, lightheaded and also vomited. The client was also diaphoretic. The client vital signs were stable upon paramedics arrival. The client stated that she had allergies to prednisone, tomato,  citrus, and shellfish. Client stated her primary care physician would not give her the vaccine. This information was shared after the dose was already given.
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Dyspnoea, Loss of consciousness, Nausea, Syncope
Clinical narrative: Patient was walking in store while holding onto her mom's arm.  Mom felt her start to go down and helped her to the floor.  Patient awoke and was helped into a chair.  She stated she was also having a slight difficulty  breathing and felt nauseous.  She was observed for a few minutes and was given some water.  Patient threw up a small amount and took a drink of water.  She started feeling better and remained seated for a while.  The patient has had a history fainting with immunizations.
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Patient was walking in store while holding onto her mom's arm.  Mom felt her start to go down and helped her to the floor.  Patient awoke and was helped into a chair.  She stated she was also having a slight difficulty  breathing and felt nauseous.  She was observed for a few minutes and was given some water.  Patient threw up a small amount and took a drink of water.  She started feeling better and remained seated for a while.  The patient has had a history fainting with immunizations.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Feeling abnormal, Mobility decreased
Clinical narrative: First day I but that night I had a lot of pain, chills and little bit of fever and lot of body pain. Very fatigue and could get out of bed. "My body was out of me". By Monday I was okay, just pain in my shoulders and especially in my arms.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity, Pyrexia
Clinical narrative: First day I but that night I had a lot of pain, chills and little bit of fever and lot of body pain. Very fatigue and could get out of bed. "My body was out of me". By Monday I was okay, just pain in my shoulders and especially in my arms.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Expired vaccine administered.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Patient was to receive the Moderna Booster 0.25ml. But actually received the Moderna 0.5ml. Patient notified and no adverse effects noted
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Aphasia, Borrelia test, Computerised tomogram head, Dyspnoea, Fatigue
Clinical narrative: Patient received the vaccine in November and in December she started experiencing difficulty walking and talking tried to see a doctor unable to see a doctor until January.  Went to the emergency room in February with the following symptoms: unable to move legs, difficulty moving arms, trouble breathing, pain all over difficulty with speech, vision problems, headache, excessive thirst, fatigue. CT of head, MRI of head, ophthalmologist exam, MRI cervical and spine. Neurologist reported the following: Examination demonstrates features most consistent with a myelopathy.  We will obtain spinal MRI and repulse with steroid.  We will also check Lyme tier.  A post-vaccination myelitis or Miller Fisher syndrome is a consideration.  Cysticercosis is a possibility as well.  I will request hospital records as well.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Gait disturbance, Headache, Magnetic resonance imaging head, Magnetic resonance imaging neck, Magnetic resonance imaging spinal
Clinical narrative: Patient received the vaccine in November and in December she started experiencing difficulty walking and talking tried to see a doctor unable to see a doctor until January.  Went to the emergency room in February with the following symptoms: unable to move legs, difficulty moving arms, trouble breathing, pain all over difficulty with speech, vision problems, headache, excessive thirst, fatigue. CT of head, MRI of head, ophthalmologist exam, MRI cervical and spine. Neurologist reported the following: Examination demonstrates features most consistent with a myelopathy.  We will obtain spinal MRI and repulse with steroid.  We will also check Lyme tier.  A post-vaccination myelitis or Miller Fisher syndrome is a consideration.  Cysticercosis is a possibility as well.  I will request hospital records as well.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Mobility decreased, Movement disorder, Myelopathy, Ophthalmological examination, Pain
Clinical narrative: Patient received the vaccine in November and in December she started experiencing difficulty walking and talking tried to see a doctor unable to see a doctor until January.  Went to the emergency room in February with the following symptoms: unable to move legs, difficulty moving arms, trouble breathing, pain all over difficulty with speech, vision problems, headache, excessive thirst, fatigue. CT of head, MRI of head, ophthalmologist exam, MRI cervical and spine. Neurologist reported the following: Examination demonstrates features most consistent with a myelopathy.  We will obtain spinal MRI and repulse with steroid.  We will also check Lyme tier.  A post-vaccination myelitis or Miller Fisher syndrome is a consideration.  Cysticercosis is a possibility as well.  I will request hospital records as well.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Thirst, Visual impairment
Clinical narrative: Patient received the vaccine in November and in December she started experiencing difficulty walking and talking tried to see a doctor unable to see a doctor until January.  Went to the emergency room in February with the following symptoms: unable to move legs, difficulty moving arms, trouble breathing, pain all over difficulty with speech, vision problems, headache, excessive thirst, fatigue. CT of head, MRI of head, ophthalmologist exam, MRI cervical and spine. Neurologist reported the following: Examination demonstrates features most consistent with a myelopathy.  We will obtain spinal MRI and repulse with steroid.  We will also check Lyme tier.  A post-vaccination myelitis or Miller Fisher syndrome is a consideration.  Cysticercosis is a possibility as well.  I will request hospital records as well.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Confusional state, Encephalitis, Headache, Photophobia, Tinnitus
Clinical narrative: 12 hours after booster there was 12 hours of symptoms of cerebritis with headache, photophobia, mild confusion, and wooshing tinnitus. The tinnitus has remained after six months but after five months decreased in its intensity by about 50%. It does not interfere when I am working or occupied. It does not disturb my sleep.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Diplopia, Incorrect dose administered, Strabismus, VIth nerve paralysis
Clinical narrative: Dose 3: Full dose Moderna, 08/20/2021, 088D21A. I had double vision, noticed around the first of the year. I made an appoint to see ophthalmologist and I was referred on to a specialist 01/10//022, provided the diagnosis of  Diagnosed as 6 nerve palsy. Diagnosis of New onset Esotropia was Dr. (Privacy) was referred to the Nero-Ophthalmology Dr. (Privacy).
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Death
Clinical narrative: per death certificate, pt died at a local HCF with condition contributing to death as COVID 19
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Diarrhoea, Dyspnoea, Fatigue
Clinical narrative: Case completed primary 2 dose series, and  booster for Covid by August 2021, then was hospitalized for Covid in January 2022 Hospitalized at:  local Hospital.   COVID-19 Assessment & Plan Patient had mild symptom onset on 1/17 followed by worsening symptoms and positive test on on 1/19 and has had progressive symptoms since that time. She had a second positive home antigen test on 1/29. Has dyspnea, cough, nausea, diarrhea, and fatigue. Fully vaccinated with booster - Decadron 6 mg daily, currently on day 6 of a 10-day course which she will finish at home. Completed 5 days of remdesivir - No role for systemic abx, briefly started on admission but quickly stopped with no evidence of bacterial infection -Completed isolation - Full code
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Nausea, SARS-CoV-2 test positive
Clinical narrative: Case completed primary 2 dose series, and  booster for Covid by August 2021, then was hospitalized for Covid in January 2022 Hospitalized at:  local Hospital.   COVID-19 Assessment & Plan Patient had mild symptom onset on 1/17 followed by worsening symptoms and positive test on on 1/19 and has had progressive symptoms since that time. She had a second positive home antigen test on 1/29. Has dyspnea, cough, nausea, diarrhea, and fatigue. Fully vaccinated with booster - Decadron 6 mg daily, currently on day 6 of a 10-day course which she will finish at home. Completed 5 days of remdesivir - No role for systemic abx, briefly started on admission but quickly stopped with no evidence of bacterial infection -Completed isolation - Full code
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Biopsy, Blood test normal, Condition aggravated, Lymphomatoid papulosis, Positron emission tomogram normal
Clinical narrative: Starting a few weeks after receiving the vaccine, I developed a significant outbreak of a now diagnosed lymphomatoid papulosis on my right forearm. I went to see the dermatologist who took a biopsy and then I was referred to an oncologist. After numerous tests, they determined it was not cancer and rather it was lymphomatoid papulosis. The same thing happened after the booster dose (10/21/2021) and that outbreak was worse. The lesion that formed is actually still present to this day in the right arm pit.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Skin lesion
Clinical narrative: Starting a few weeks after receiving the vaccine, I developed a significant outbreak of a now diagnosed lymphomatoid papulosis on my right forearm. I went to see the dermatologist who took a biopsy and then I was referred to an oncologist. After numerous tests, they determined it was not cancer and rather it was lymphomatoid papulosis. The same thing happened after the booster dose (10/21/2021) and that outbreak was worse. The lesion that formed is actually still present to this day in the right arm pit.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Fatigue, Headache, Oropharyngeal pain
Clinical narrative: Headache, coughing, sore throat, tiredness and fatigue. I ended going to the doctor who did a check up and sent me home to rest and recover.
Age: 80.0
Sex: F
Vaccine: UNK
Symptoms: Blister, Burning sensation, Erythema, Herpes zoster, Paraesthesia
Clinical narrative: 8 small (1/16") Zoster skin eruptions  appeared on left breast on March 10--very itchy, tingling, burning; then still itchy tingling, burning & larger (1/8") for 2 days; small blisters (1/8") started to form on 3rd and   4th day - still itchy, tingling, and burning. I start taking Acyclovir 200 mg 5x a day; blisters begin to develop a surrounding red area and a yellow-ish center and expanded to 3/16" on 5th day. By 7th day, the blistery, red areas were larger (1/4"). Still taking Acyclovir 200 mg on 5th, 6th, 7th day; went to Urgent Care for diagnosis on 7th day (March 16); diagnosed as Shingles; advised to continue Acyclovir 200 mg, and to use Acyclovir 5% ointment 4x a day; Drug Plan would not cover the ointment; I continued Acyclovir 200 mg on 8th and 9th day (30 capsules by then), but still had itchy, burning sensation, and the 8 areas were still 1/4" each.  On 10th & 11th day I was still waiting for Plan approval of Acyclovir ointment; On 12th day, I called Urgent Care to see why had not approved the ointment and was told that I needed instead to take 800 mg Acyclovir 5x a day for 7 days;  Rx was then filled on 12th day;  itching, tingling, burning began to subside on 13th day; now on March 25 (day 16) blisters have started drying up [blisters never broke open]
Age: 80.0
Sex: F
Vaccine: UNK
Symptoms: Rash, Rash pruritic, Skin discolouration
Clinical narrative: 8 small (1/16") Zoster skin eruptions  appeared on left breast on March 10--very itchy, tingling, burning; then still itchy tingling, burning & larger (1/8") for 2 days; small blisters (1/8") started to form on 3rd and   4th day - still itchy, tingling, and burning. I start taking Acyclovir 200 mg 5x a day; blisters begin to develop a surrounding red area and a yellow-ish center and expanded to 3/16" on 5th day. By 7th day, the blistery, red areas were larger (1/4"). Still taking Acyclovir 200 mg on 5th, 6th, 7th day; went to Urgent Care for diagnosis on 7th day (March 16); diagnosed as Shingles; advised to continue Acyclovir 200 mg, and to use Acyclovir 5% ointment 4x a day; Drug Plan would not cover the ointment; I continued Acyclovir 200 mg on 8th and 9th day (30 capsules by then), but still had itchy, burning sensation, and the 8 areas were still 1/4" each.  On 10th & 11th day I was still waiting for Plan approval of Acyclovir ointment; On 12th day, I called Urgent Care to see why had not approved the ointment and was told that I needed instead to take 800 mg Acyclovir 5x a day for 7 days;  Rx was then filled on 12th day;  itching, tingling, burning began to subside on 13th day; now on March 25 (day 16) blisters have started drying up [blisters never broke open]
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Expired vaccine administered.
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: Patient was given pediatric dose 0.2 mL, instead of adult dose based on age.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: EXPIRED DOSE ADMINISTERED.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Emotional distress, Fatigue, Insomnia, Rash
Clinical narrative: Itchy rashes all over the body. The rashes started on the arms, after 2 days it became severe to the point I could not sleep. I went to see dermatologist the next day. I was prescribed Antihistamine and ointment which provided temp. relief for first 2 days. Then itching rashes started to become more severe. So I consulted homeopathic clinic. Its been 2 weeks since the onset of the rashes and I feel exhausted from lack of sleep, fatigue and mental stress.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Rash pruritic
Clinical narrative: Itchy rashes all over the body. The rashes started on the arms, after 2 days it became severe to the point I could not sleep. I went to see dermatologist the next day. I was prescribed Antihistamine and ointment which provided temp. relief for first 2 days. Then itching rashes started to become more severe. So I consulted homeopathic clinic. Its been 2 weeks since the onset of the rashes and I feel exhausted from lack of sleep, fatigue and mental stress.
Age: 62.0
Sex: F
Vaccine: FLU4
Symptoms: Arthralgia
Clinical narrative: pain in shoulder
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Ear pain, Headache, Hypoaesthesia, Paraesthesia oral
Clinical narrative: 3/25/2022 at 1317 Employee called the Nurse Vaccine Support line to report symptoms post COVID-19 booster vaccine. Vaccine Name - Pfizer Vaccine Date - 3/23/2022 Booster Dose - Yes Location - Right Deltoid Date of Symptom Onset - 3/24/2022  Symptoms - Severe Diarrhea, Numbness to Right Side of Face, Tingling & Itching of Tongue, Headache, Ear Pain, Fever (Tmax 100F) Last Day of Work and Shift - 3/23/2022 (830a - 5p) Home Remedies - Tylenol 500 mg Every 6 Hours through Present (Started on 3/23/2022 at 3p prior to injection per Transplant HCP instructions) Any Improvement - No
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Tongue pruritus
Clinical narrative: 3/25/2022 at 1317 Employee called the Nurse Vaccine Support line to report symptoms post COVID-19 booster vaccine. Vaccine Name - Pfizer Vaccine Date - 3/23/2022 Booster Dose - Yes Location - Right Deltoid Date of Symptom Onset - 3/24/2022  Symptoms - Severe Diarrhea, Numbness to Right Side of Face, Tingling & Itching of Tongue, Headache, Ear Pain, Fever (Tmax 100F) Last Day of Work and Shift - 3/23/2022 (830a - 5p) Home Remedies - Tylenol 500 mg Every 6 Hours through Present (Started on 3/23/2022 at 3p prior to injection per Transplant HCP instructions) Any Improvement - No
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal distension, Chills, Decreased appetite, Fatigue, Headache
Clinical narrative: Persistent headache (5 weeks) - Extra Strength Tylenol Persistent nausea - untreated Persistent bloatedness - untreated Lack of appetite - untreated Sleep disturbance - untreated Chills - untreated Exhaustion - untreated Inability to work for first three of the five weeks
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Impaired work ability, Nausea, Sleep disorder
Clinical narrative: Persistent headache (5 weeks) - Extra Strength Tylenol Persistent nausea - untreated Persistent bloatedness - untreated Lack of appetite - untreated Sleep disturbance - untreated Chills - untreated Exhaustion - untreated Inability to work for first three of the five weeks
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: EXPIRED DOSE ADMINISTERED.
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: patient was 11 when getting Pfizer 5-11 yr vaccine as first dose and turned 12 years old already , we suggested to get adult Pfizer but parent checked with patient's pediatrician and doctor suggested keep the same Pfizer 5-11yr as second dose, So the pharmacist gave the Pfizer 5-11yr as second dose for the patient that just turned 12.
Age: 32.0
Sex: F
Vaccine: MNQ, TYP, YF
Symptoms: Anaphylactic reaction, Chest pain, Dyspnoea, Odynophagia, Urticaria
Clinical narrative: Anaphylaxis about 15 minutes after the injections.  Chest pain, shortness of breath, hives, pain with swallowing.  She was given an EpiPen, put on oxygen, vital signs monitored and were stable.  Patient was transported to a local emergency room.  Recovered.  Referred to allergist for further evaluation
Age: 11.0
Sex: M
Vaccine: HPV9, VARCEL
Symptoms: Erythema, Injection site erythema, Injection site rash, Vomiting
Clinical narrative: Patient received vaccination on 03/22/22 in the morning .Mom reported end of day on 03/24/22 that the patient developped redness on injection site followed by rash 1-2 days after receiving the vaccines.  abd vomiting once. Denies fever  chest pain or Shortness of breath. Patient was seen in clinic on 03/25/22 by a provider and had patchy endurated erythema. Provider assessment points to likely due to 1st dose of HPV vaccine
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Angiogram pulmonary normal, Blood glucose increased, COVID-19, Chest X-ray normal, Dyspnoea
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 2/10/21 (el3302) Pfizer Dose 2 3/4/21 (EN6199) Pfizer Dose 3 10/20/21 (lot not listed in database) COVID Positive 10/24/21  10/24/21: Patient is an 80-year-old male who presents to the ED today after being seen at Facility for shortness of breath. The patient has a past medical history significant for asthma, type 2 diabetes, OSA, HLD, HTN. The patient tested positive for COVID-19 today while at Facility, at which time patient pulse ox was low on room air.  The patient was encouraged to proceed to the emergency department for further evaluation.  The patient is vaccinated against COVID-19 and received his booster vaccination on Wednesday. He denies any fever, chills, body aches, chest pain, nausea, vomiting or diarrhea. His accompanying symptoms include headache, SOB and a productive cough.  Patient was seen and examined at the bedside in the ED.  the patient states he feels much improved since arrival and his shortness of breath is improved.   Upon arrival to ED patient's temperature is 99.3°, heart rate 105, respirations 26, pulse ox 86% on room air, blood pressure 215/92.  The patient was placed on 3 L oxygen via nasal cannula to maintain O2 saturations greater than 90%. Patient's chest x-ray revealed no acute cardiopulmonary process.  CTA chest completed which revealed no PE. Patient's laboratory findings are significant for glucose 234. The patient received 10 mg p.o. amlodipine, 30 mg IV Toradol, 2.7 L IV LR, 750 mg IV Levaquin.  10/27/21: Discharge Plan: P.o. azithromycin course  P.o. Decadron  P.o. zinc sulfate and vitamin-C  COVID-19 precautions per CDC guidelines  Hemodynamically stable for discharge  Will discharge home  Follow-up with PCP in 3-5 days  Patient agrees with plan of care
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Inappropriate schedule of product administration, Oxygen saturation decreased, Productive cough, SARS-CoV-2 test positive
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 2/10/21 (el3302) Pfizer Dose 2 3/4/21 (EN6199) Pfizer Dose 3 10/20/21 (lot not listed in database) COVID Positive 10/24/21  10/24/21: Patient is an 80-year-old male who presents to the ED today after being seen at Facility for shortness of breath. The patient has a past medical history significant for asthma, type 2 diabetes, OSA, HLD, HTN. The patient tested positive for COVID-19 today while at Facility, at which time patient pulse ox was low on room air.  The patient was encouraged to proceed to the emergency department for further evaluation.  The patient is vaccinated against COVID-19 and received his booster vaccination on Wednesday. He denies any fever, chills, body aches, chest pain, nausea, vomiting or diarrhea. His accompanying symptoms include headache, SOB and a productive cough.  Patient was seen and examined at the bedside in the ED.  the patient states he feels much improved since arrival and his shortness of breath is improved.   Upon arrival to ED patient's temperature is 99.3°, heart rate 105, respirations 26, pulse ox 86% on room air, blood pressure 215/92.  The patient was placed on 3 L oxygen via nasal cannula to maintain O2 saturations greater than 90%. Patient's chest x-ray revealed no acute cardiopulmonary process.  CTA chest completed which revealed no PE. Patient's laboratory findings are significant for glucose 234. The patient received 10 mg p.o. amlodipine, 30 mg IV Toradol, 2.7 L IV LR, 750 mg IV Levaquin.  10/27/21: Discharge Plan: P.o. azithromycin course  P.o. Decadron  P.o. zinc sulfate and vitamin-C  COVID-19 precautions per CDC guidelines  Hemodynamically stable for discharge  Will discharge home  Follow-up with PCP in 3-5 days  Patient agrees with plan of care
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccine breakthrough infection
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 2/10/21 (el3302) Pfizer Dose 2 3/4/21 (EN6199) Pfizer Dose 3 10/20/21 (lot not listed in database) COVID Positive 10/24/21  10/24/21: Patient is an 80-year-old male who presents to the ED today after being seen at Facility for shortness of breath. The patient has a past medical history significant for asthma, type 2 diabetes, OSA, HLD, HTN. The patient tested positive for COVID-19 today while at Facility, at which time patient pulse ox was low on room air.  The patient was encouraged to proceed to the emergency department for further evaluation.  The patient is vaccinated against COVID-19 and received his booster vaccination on Wednesday. He denies any fever, chills, body aches, chest pain, nausea, vomiting or diarrhea. His accompanying symptoms include headache, SOB and a productive cough.  Patient was seen and examined at the bedside in the ED.  the patient states he feels much improved since arrival and his shortness of breath is improved.   Upon arrival to ED patient's temperature is 99.3°, heart rate 105, respirations 26, pulse ox 86% on room air, blood pressure 215/92.  The patient was placed on 3 L oxygen via nasal cannula to maintain O2 saturations greater than 90%. Patient's chest x-ray revealed no acute cardiopulmonary process.  CTA chest completed which revealed no PE. Patient's laboratory findings are significant for glucose 234. The patient received 10 mg p.o. amlodipine, 30 mg IV Toradol, 2.7 L IV LR, 750 mg IV Levaquin.  10/27/21: Discharge Plan: P.o. azithromycin course  P.o. Decadron  P.o. zinc sulfate and vitamin-C  COVID-19 precautions per CDC guidelines  Hemodynamically stable for discharge  Will discharge home  Follow-up with PCP in 3-5 days  Patient agrees with plan of care
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Scleritis
Clinical narrative: Member developed anterior scleritis of her right eye in Dec 2021 one month after receiving dose #2 of the COVID-19 vaccination and required care at hospital.
Age: 65.0
Sex: F
Vaccine: PNC20
Symptoms: Lip swelling, Paraesthesia oral
Clinical narrative: tingling tounge, mild lip swelling
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dysphagia, Head injury, Loss of consciousness, Migraine
Clinical narrative: Woke up at 1am  very nauseous, had a fever, chills and was shaking really bad. Could barely swallow. I got up to get a drink and passed out on the floor hitting my head. When I came to went into my bed shaking and  the next day had a migraine  and my whole body was sore.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain, Pyrexia, Tremor
Clinical narrative: Woke up at 1am  very nauseous, had a fever, chills and was shaking really bad. Could barely swallow. I got up to get a drink and passed out on the floor hitting my head. When I came to went into my bed shaking and  the next day had a migraine  and my whole body was sore.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Anaemia, Anticoagulant therapy, Arthralgia, Blood calcium decreased, COVID-19
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 2/25/21 (EL9266) Pfizer Dose 2 3/19/21 (EN6204) COVID Positive 10/26/21  10/26/21: Patient is a 91 year old male who lives at home with his daughter at baseline who presented to ED with complaints of bilateral hip pain.  Patient is ambulatory with a cane at home.  History was obtained per the patient and his daughter who is at bedside.  Yesterday, the patient suffered 2 falls.  First fall occurred when he slipped out of bed in the morning. His second fall occurred when he was going to bed last night. He hit his head on his nightstand, denies loc. He is anticoagulated on Eliquis.  His hip pain is worse with standing and ambulating.  He denies any chest pain or shortness of breath.  No recent fevers.  No nausea, vomiting or diarrhea.  Patient has a past medical history significant for atrial fibrillation anticoagulated on Eliquis, history of DVT, CAD status post stenting, PVD, hypertension, hyperlipidemia, GERD, BPH, OSA on CPAP, anxiety/depression and CHF LVEF 55%.  Arrival to ED the patient was febrile 101.3, saturating on room air at 91%.  Laboratory findings were significant for hypocalcemia 8.4.  Anemia HGB 12.1.  Chest x-ray showed new by basilar airspace disease which may represent atelectasis or infiltrates.  Levaquin was initiated in ED and IV hydration was given with NS 0.9% 1 L bolus. X-ray of pelvis showed no acute traumatic injury.  10/29/21: Patient is a 91 year old male who lives at home with his daughter,presented to ED with complaints of bilateral hip pain and falls.  Patient is ambulatory with a cane at home.  He was  feeling fatigued recently tested positive for COVID-19 infection and started on treatment.  Patient saturation okay with desaturation room.  No recent fevers.  No nausea, vomiting or diarrhea. Patient has a past medical history significant for atrial fibrillation anticoagulated on Eliquis, history of DVT, CAD status post stenting, PVD, hypertension, hyperlipidemia, GERD, BPH, OSA on CPAP, anxiety/depression and CHF LVEF 55%.  Chest x-ray showed new by basilar airspace disease which may represent atelectasis or infiltrates from COVID-19 infection.  Patient was initially started on IV levofloxacin  This has been discontinued because of absence of fever, leukocytosis or symptoms  The patient will be discharged to home with family.  He needs to follow with PT/OT as outpatient
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Chest X-ray abnormal, Fall, Fatigue, Haemoglobin decreased, Head injury
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 2/25/21 (EL9266) Pfizer Dose 2 3/19/21 (EN6204) COVID Positive 10/26/21  10/26/21: Patient is a 91 year old male who lives at home with his daughter at baseline who presented to ED with complaints of bilateral hip pain.  Patient is ambulatory with a cane at home.  History was obtained per the patient and his daughter who is at bedside.  Yesterday, the patient suffered 2 falls.  First fall occurred when he slipped out of bed in the morning. His second fall occurred when he was going to bed last night. He hit his head on his nightstand, denies loc. He is anticoagulated on Eliquis.  His hip pain is worse with standing and ambulating.  He denies any chest pain or shortness of breath.  No recent fevers.  No nausea, vomiting or diarrhea.  Patient has a past medical history significant for atrial fibrillation anticoagulated on Eliquis, history of DVT, CAD status post stenting, PVD, hypertension, hyperlipidemia, GERD, BPH, OSA on CPAP, anxiety/depression and CHF LVEF 55%.  Arrival to ED the patient was febrile 101.3, saturating on room air at 91%.  Laboratory findings were significant for hypocalcemia 8.4.  Anemia HGB 12.1.  Chest x-ray showed new by basilar airspace disease which may represent atelectasis or infiltrates.  Levaquin was initiated in ED and IV hydration was given with NS 0.9% 1 L bolus. X-ray of pelvis showed no acute traumatic injury.  10/29/21: Patient is a 91 year old male who lives at home with his daughter,presented to ED with complaints of bilateral hip pain and falls.  Patient is ambulatory with a cane at home.  He was  feeling fatigued recently tested positive for COVID-19 infection and started on treatment.  Patient saturation okay with desaturation room.  No recent fevers.  No nausea, vomiting or diarrhea. Patient has a past medical history significant for atrial fibrillation anticoagulated on Eliquis, history of DVT, CAD status post stenting, PVD, hypertension, hyperlipidemia, GERD, BPH, OSA on CPAP, anxiety/depression and CHF LVEF 55%.  Chest x-ray showed new by basilar airspace disease which may represent atelectasis or infiltrates from COVID-19 infection.  Patient was initially started on IV levofloxacin  This has been discontinued because of absence of fever, leukocytosis or symptoms  The patient will be discharged to home with family.  He needs to follow with PT/OT as outpatient
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Hypocalcaemia, Lung disorder, Oxygen saturation decreased, Pain, Pyrexia
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 2/25/21 (EL9266) Pfizer Dose 2 3/19/21 (EN6204) COVID Positive 10/26/21  10/26/21: Patient is a 91 year old male who lives at home with his daughter at baseline who presented to ED with complaints of bilateral hip pain.  Patient is ambulatory with a cane at home.  History was obtained per the patient and his daughter who is at bedside.  Yesterday, the patient suffered 2 falls.  First fall occurred when he slipped out of bed in the morning. His second fall occurred when he was going to bed last night. He hit his head on his nightstand, denies loc. He is anticoagulated on Eliquis.  His hip pain is worse with standing and ambulating.  He denies any chest pain or shortness of breath.  No recent fevers.  No nausea, vomiting or diarrhea.  Patient has a past medical history significant for atrial fibrillation anticoagulated on Eliquis, history of DVT, CAD status post stenting, PVD, hypertension, hyperlipidemia, GERD, BPH, OSA on CPAP, anxiety/depression and CHF LVEF 55%.  Arrival to ED the patient was febrile 101.3, saturating on room air at 91%.  Laboratory findings were significant for hypocalcemia 8.4.  Anemia HGB 12.1.  Chest x-ray showed new by basilar airspace disease which may represent atelectasis or infiltrates.  Levaquin was initiated in ED and IV hydration was given with NS 0.9% 1 L bolus. X-ray of pelvis showed no acute traumatic injury.  10/29/21: Patient is a 91 year old male who lives at home with his daughter,presented to ED with complaints of bilateral hip pain and falls.  Patient is ambulatory with a cane at home.  He was  feeling fatigued recently tested positive for COVID-19 infection and started on treatment.  Patient saturation okay with desaturation room.  No recent fevers.  No nausea, vomiting or diarrhea. Patient has a past medical history significant for atrial fibrillation anticoagulated on Eliquis, history of DVT, CAD status post stenting, PVD, hypertension, hyperlipidemia, GERD, BPH, OSA on CPAP, anxiety/depression and CHF LVEF 55%.  Chest x-ray showed new by basilar airspace disease which may represent atelectasis or infiltrates from COVID-19 infection.  Patient was initially started on IV levofloxacin  This has been discontinued because of absence of fever, leukocytosis or symptoms  The patient will be discharged to home with family.  He needs to follow with PT/OT as outpatient
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Vaccine breakthrough infection, Walking aid user, X-ray of pelvis and hip normal
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 2/25/21 (EL9266) Pfizer Dose 2 3/19/21 (EN6204) COVID Positive 10/26/21  10/26/21: Patient is a 91 year old male who lives at home with his daughter at baseline who presented to ED with complaints of bilateral hip pain.  Patient is ambulatory with a cane at home.  History was obtained per the patient and his daughter who is at bedside.  Yesterday, the patient suffered 2 falls.  First fall occurred when he slipped out of bed in the morning. His second fall occurred when he was going to bed last night. He hit his head on his nightstand, denies loc. He is anticoagulated on Eliquis.  His hip pain is worse with standing and ambulating.  He denies any chest pain or shortness of breath.  No recent fevers.  No nausea, vomiting or diarrhea.  Patient has a past medical history significant for atrial fibrillation anticoagulated on Eliquis, history of DVT, CAD status post stenting, PVD, hypertension, hyperlipidemia, GERD, BPH, OSA on CPAP, anxiety/depression and CHF LVEF 55%.  Arrival to ED the patient was febrile 101.3, saturating on room air at 91%.  Laboratory findings were significant for hypocalcemia 8.4.  Anemia HGB 12.1.  Chest x-ray showed new by basilar airspace disease which may represent atelectasis or infiltrates.  Levaquin was initiated in ED and IV hydration was given with NS 0.9% 1 L bolus. X-ray of pelvis showed no acute traumatic injury.  10/29/21: Patient is a 91 year old male who lives at home with his daughter,presented to ED with complaints of bilateral hip pain and falls.  Patient is ambulatory with a cane at home.  He was  feeling fatigued recently tested positive for COVID-19 infection and started on treatment.  Patient saturation okay with desaturation room.  No recent fevers.  No nausea, vomiting or diarrhea. Patient has a past medical history significant for atrial fibrillation anticoagulated on Eliquis, history of DVT, CAD status post stenting, PVD, hypertension, hyperlipidemia, GERD, BPH, OSA on CPAP, anxiety/depression and CHF LVEF 55%.  Chest x-ray showed new by basilar airspace disease which may represent atelectasis or infiltrates from COVID-19 infection.  Patient was initially started on IV levofloxacin  This has been discontinued because of absence of fever, leukocytosis or symptoms  The patient will be discharged to home with family.  He needs to follow with PT/OT as outpatient
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Patient was administered vaccine on 3/25/2022 that expired on 3/24/2022.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Cough, Fatigue, Feeling abnormal, Illness
Clinical narrative: I started experiencing flu like symptoms with an hour of vaccination, and have experienced chronic fatigue since dose 1. I have a feeling of brain fog and overall not feeling well and being sick with a cough.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Malaise
Clinical narrative: I started experiencing flu like symptoms with an hour of vaccination, and have experienced chronic fatigue since dose 1. I have a feeling of brain fog and overall not feeling well and being sick with a cough.
Age: 97.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure systolic decreased, COVID-19, Chest X-ray abnormal, Confusional state, Death
Clinical narrative: 9/6/21 EMS brought pt to ED with confusion and reported low systolic BP; BP was WNL in ED but chest x-ray showed multifocal pneumonia; antibiotic given; admitted to hospital; records do not show when pt was discharged to a nursing home; record of positive COVID test on 10/9/21, unsure if this was in hosp or nursing home; per death certificate the pt died in the nursing home and the causes of death were Hypoxic Respiratory Failure and COVID 19 infection and associated pneumonia
Age: 97.0
Sex: F
Vaccine: COVID19
Symptoms: Pneumonia, Respiratory failure, SARS-CoV-2 test positive
Clinical narrative: 9/6/21 EMS brought pt to ED with confusion and reported low systolic BP; BP was WNL in ED but chest x-ray showed multifocal pneumonia; antibiotic given; admitted to hospital; records do not show when pt was discharged to a nursing home; record of positive COVID test on 10/9/21, unsure if this was in hosp or nursing home; per death certificate the pt died in the nursing home and the causes of death were Hypoxic Respiratory Failure and COVID 19 infection and associated pneumonia
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: EXPIRED DOSE ADMINISTERED.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Blood pressure increased, COVID-19, Chest X-ray, Chest pain
Clinical narrative: COVID Vaccine Breakthrough Case  J&J Dose 7/23/21 (206A21A) COVID Positive 10/27/21  10/26/21: Patient is an African American male with past medical history of hypertension not on any medication, asthma, history of gun shot who presented to the ED with fatigue, shortness of breath cough, chills and body ache.  Patient reports he has been sick for the past 6 days.  Patient has also been having abdomen pain, nausea vomiting.  Two days ago patient reports he was vomiting and he passed out.  Patient also reports left-sided midclavicular to chest pain, intermittent, 5/10, nonradiating, worse with coughing and no alleviating factor.  Patient took the J&J COVID 19 vaccine in July 2021. Patient smokes marijuana intermittently.  Patient reports he has not been taking blood pressure medication for some years.   Patient did test + COVID 19 4 days ago. Family history significant for both parents dying from MI in the 50s, cousin dying from MI 3 weeks ago at age 40.At this time patient endorses headache have but denies fever, abdomen pain, blurred vision, dizziness or any focal deficits.   Initially in the ED blood pressure 193/125, heart rate 97, RR 22, 100% room air, temp 99.8°.  Chest x-ray did not show any acute process, official read pending.  CT head negative for acute intracranial abnormality, did note sinusitis. Lab works not remarkable.  Patient received nitro in the ED.  10/28/21:  40-year-old man presented with complaints of chest discomfort, nausea, generalized malaise following recent COVID diagnosis.  He is fully vaccinated,  apprehensive about COVID diagnosis as both parents died of COVID last year.  Blood pressures were noted to be markedly elevated on presentation to the emergency department, known history of hypertension noncompliant with medications and has lost primary care provider.  He was admitted to the hospitalist Service, has remained minimally symptomatic and hemodynamically stable with no oxygen requirements.  At this time he does not meet criteria for inpatient treatment for COVID infection with antiviral therapy, steroids or Actemra.  He was started on oral antihypertensive with improvement in blood pressures, medication compliance and the need to establish care with primary care has been counseled.  He has been discharged in stable medical condition to be followed up by the COVID safe at home program.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Computerised tomogram head abnormal, Cough, Dyspnoea, Fatigue
Clinical narrative: COVID Vaccine Breakthrough Case  J&J Dose 7/23/21 (206A21A) COVID Positive 10/27/21  10/26/21: Patient is an African American male with past medical history of hypertension not on any medication, asthma, history of gun shot who presented to the ED with fatigue, shortness of breath cough, chills and body ache.  Patient reports he has been sick for the past 6 days.  Patient has also been having abdomen pain, nausea vomiting.  Two days ago patient reports he was vomiting and he passed out.  Patient also reports left-sided midclavicular to chest pain, intermittent, 5/10, nonradiating, worse with coughing and no alleviating factor.  Patient took the J&J COVID 19 vaccine in July 2021. Patient smokes marijuana intermittently.  Patient reports he has not been taking blood pressure medication for some years.   Patient did test + COVID 19 4 days ago. Family history significant for both parents dying from MI in the 50s, cousin dying from MI 3 weeks ago at age 40.At this time patient endorses headache have but denies fever, abdomen pain, blurred vision, dizziness or any focal deficits.   Initially in the ED blood pressure 193/125, heart rate 97, RR 22, 100% room air, temp 99.8°.  Chest x-ray did not show any acute process, official read pending.  CT head negative for acute intracranial abnormality, did note sinusitis. Lab works not remarkable.  Patient received nitro in the ED.  10/28/21:  40-year-old man presented with complaints of chest discomfort, nausea, generalized malaise following recent COVID diagnosis.  He is fully vaccinated,  apprehensive about COVID diagnosis as both parents died of COVID last year.  Blood pressures were noted to be markedly elevated on presentation to the emergency department, known history of hypertension noncompliant with medications and has lost primary care provider.  He was admitted to the hospitalist Service, has remained minimally symptomatic and hemodynamically stable with no oxygen requirements.  At this time he does not meet criteria for inpatient treatment for COVID infection with antiviral therapy, steroids or Actemra.  He was started on oral antihypertensive with improvement in blood pressures, medication compliance and the need to establish care with primary care has been counseled.  He has been discharged in stable medical condition to be followed up by the COVID safe at home program.